In a 9-year study of 413 patients with COPD, a high level of plasma GDF15 was independently associated with higher exacerbation rates, higher mortality, and a more significant decrease in the forced expiratory volume in 1 s and forced vital capacities [103]. Here, GDF15 is linked to chronic obstructive pulmonary disease.